|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cancer vaccines 显示文摘 | Rousseau RF Hirscbmann-Jax C Takahashi S | 2001 | Hematol Oncol Clin North Am2001，15，4： | 1 |
| 2 | Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carbopla- tin in combination with photon irradiation显示文摘 | Rousseau J Boudou C Barth RF | 2007 | Clin Cancer Res2007，13，17： | 1 |
| 3 | Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats显示文摘 | Rousseau J Barth RF Moesehberger ML | 2009 | Int J Radiat Oncol Biol Phys2009，73，2： | 1 |
| 4 | Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 5 | Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation fo rtreat- ment of brain tumors显示文摘 | Rousseau J Barth RF Fernandez M | 2010 | J Neurooneol2010，98，3： | 1 |
| 6 | Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors显示文摘 | Rousseau J Barth RF Fernandez M | 2010 | J Neuroaneol2010，98，3： | 1 |
| 7 | Immunotherapy of high-risk acute leukemia with a recipient (autologous) vac- cine expressing transgenic human CIMOL and IL-2 after chemotherapy and allogeneic stem cell transplantation显示文摘 | Rousseau RF Biagi E Dutour A | 2006 | Blood2006，107，4： | 1 |
| 8 | Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 9 | Overexpression of the Notch ligand,Jagged-1,induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 10 | Overexpression of the Notch ligand,Jagged-1,induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，： | 1 |
| 11 | Overexpression of the Notch ligand, Jagged1, induces alloantigenspecific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 12 | Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma显示文摘 | Rousseau RF Haight AE Hirschmann-Jax C | 2003 | Blood2003，101，： | 1 |
| 13 | Cancer vaccines 显示文摘 | Rousseau RF Hirschmann-Jax C Takahashi S | 2001 | Hematol Oncol Clin NorthAm2001，15，4： | 1 |
| 14 | Overexpression of the Notch ligand,Jagged-1,induces alloantigen-specific human regulatory T-cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 15 | IMANN-JAX C, et aL Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refectory neuroblastoma显示文摘 | ROUSSEAU RF HAIGHT AlE HIBSCH | 2003 | Blood2003，101，： | 1 |
| 16 | Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma显示文摘 | Rousseau RF Haight AE Hirschmann-Jax C | 2003 | Blood2003，101，5： | 1 |
| 17 | Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 18 | Over expression of the Notch ligand, Jagged-1 induces alloantigen-specific human regulatory T cells显示文摘 | Yvon ES Vigouroux S Rousseau RF | 2003 | Blood2003，102，10： | 1 |
| 19 | Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation显示文摘 | Rousseau RF Biagi E Dutour A | 2006 | Blood2006，107，4： | 1 |
| 20 | Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma显示文摘 | Rousseau RF Haight AE Hirschmann-Jax C | 2003 | Blood2003，101，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员